Global News Feed

Total
Unread
Saved
Preferences Custom News
Home Saved World Extract
Prev Back to News Next

Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain

Source: Times of India
Category: Technology
Region: General
Published: October 24, 2026 at 03:09

๐Ÿ“ Summary

In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases and 4,600 fatalities since May.

๐Ÿ”— Read Full Article at Times of India โœจ Extract Article
๐Ÿท๏ธ Keywords:
trial vaccine ebola aims against bundibugyo tumaini launch begins study

๐Ÿ’ฌ Social Media Posts

Click "Fetch Related Posts" to find social media discussions about this article

๐Ÿ“ฐ Related Articles

DRC begins vaccinating front-line healthcare workers against Ebola
Al Jazeera ยท Aug 28
Ebola vaccine trial begins in DR Congo
The Hindu ยท Oct 23
DR Congo begins vaccinating against largest and deadliest Ebola outbreak
Al Jazeera ยท Aug 29
Nigeria confirms its first Ebola case is Bundibugyo strain
The Hindu ยท Oct 21
Previous Article Next Article